Peter Keeling Sells 500,000 Shares of Diaceutics PLC (LON:DXRX) Stock

Diaceutics PLC (LON:DXRX - Get Free Report) insider Peter Keeling sold 500,000 shares of the business's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of GBX 126 ($1.68), for a total transaction of £630,000 ($841,458.53).

Diaceutics Price Performance

Diaceutics stock traded up GBX 2.50 ($0.03) during mid-day trading on Tuesday, hitting GBX 134.50 ($1.80). The company's stock had a trading volume of 126,158 shares, compared to its average volume of 123,130. The stock has a market capitalization of £113.51 million, a P/E ratio of -39.89 and a beta of 0.58. The company has a quick ratio of 9.92, a current ratio of 4.85 and a debt-to-equity ratio of 0.39. The stock's fifty day moving average price is GBX 120.36 and its two-hundred day moving average price is GBX 127.26. Diaceutics PLC has a twelve month low of GBX 106 ($1.42) and a twelve month high of GBX 151 ($2.02).

Diaceutics (LON:DXRX - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported GBX (2.02) (($0.03)) earnings per share (EPS) for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. Research analysts forecast that Diaceutics PLC will post 1.0107919 earnings per share for the current year.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.